Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome.

摘要: Background Metabolic syndrome is associated with preclinical cardiac disease and nonalcoholic fatty liver (NAFLD). It uncertain whether present in patients NAFLD without metabolic (MetS). Objective To explore NAFLD. Methods A total of 64 NAFLD, based on computed tomography scans attenuation, were identified. control group, matched to age gender, comprising 94 was also drafted. Finally, two additional groups syndrome, (n = 40) 74) Patients hypertension, diabetes mellitus, other concomitant diseases excluded from the group. Echocardiograms all reviewed. Results Severe compared a higher left ventricular mass after normalization for height2.7 (LVMHt2.7) (95% CI 0.39, 12.92) lower ratio peak "E" (early) "A" (late) diastolic filling velocities (E/A) - 0.39 -0.58, -0.19). 0.02, 0.09), 0.08), or severe 0.09) relative wall thickness (RWT). Conclusion Healthy adults adjusting body index, demonstrated significant echocardiographic changes. Our results show that disease, this association independent traditional risk factors like systemic hypertension mellitus.